Cell Therapeutics Inc. Newsletter
-
Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering
27 Jan 2025 21:14 GMT
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: … other jurisdiction.
About Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics is a clinical-stage …
-
Stem Cell Therapy For Diabetes Related Conditions Market Forecasted USD 95.71 Billion By 2032, at an 12.28 % CAGR
31 Jan 2025 10:05 GMT
… Cell Therapy Center, LLC
Lineage Cell Therapeutics
Viacyte
Alkemis Therapeutics
ISCO Industries …
-
Autologous Cell Therapy Market Expected To Reach US$ 33.1 Billion By 2033, Fueled By Technological Advancements
31 Jan 2025 08:56 GMT
… in this sector include BrainStorm Cell Therapeutics, Bristol Myers Squibb, Holostem Terapie … market.
Key Market Players:
•BrainStorm Cell Therapeutics
•Holostem Terapie Avanzate S.R …
-
Lineage Cell Therapeutics Issues Letter to Stockholders
06 Jan 2025 13:20 GMT
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: … , CEO
Lineage Cell Therapeutics, Inc.
About Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics is a clinical …
-
BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update
09 Dec 2024 12:34 GMT
… developer of adult stem cell therapeutics for neurodegenerative diseases, announced … here.
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is a … future success of BrainStorm Cell Therapeutics. All statements, other …
-
MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments
30 Jan 2025 07:00 GMT
… and commercialization of next-generation cell therapeutics announced today the acquisition of …
-
Brainstorm Cell Therapeutics To Host KOL Webinar On Current Developments In The Treatment Of Amyotrophic Lateral Sclerosis (ALS) On December 11, 2024
02 Dec 2024 12:38 GMT
… developer of adult stem cell therapeutics for neurodegenerative diseases, … neurology.
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is … innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases …
-
Hemostemix Announces First Sales Orders For ACP-01
29 Jan 2025 22:42 GMT
… its patented blood-based stem cell therapeutics platform. Hemostemix is focused on …
-
Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering
21 Nov 2024 22:04 GMT
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: … other jurisdiction.
About Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics is a clinical-stage …
-
Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
20 Nov 2024 13:13 GMT
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: … other jurisdiction.
About Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics is a clinical-stage …
About
© 1995-2025